Reaktion #629670

ord-da3965f4a61a4f13bdb685ec961ddfa3

Reaktionsgleichung

CCOC(=O)Cl
Ethyl chloroformate
O=C(O)CCc1c[nH]cn1
3-(imidazol-4-yl)propionic acid
CCN(CC)CC
triethylamine
CN(C)C=O
DMF
NCCCCCc1nccc(NC(N)=NCC(F)(F)F)n1
4-[2-(2,2,2-Trifluoroethyl)guanidino]-2-(5-aminopentyl)pyrimidine
CN(C)C=O
DMF
NC(=NCC(F)(F)F)Nc1ccnc(CCCCCNC(=O)CCc2c[nH]cn2)n1.NC(=NCC(F)(F)F)Nc1ccnc(CCCCCNC(=O)CCc2c[nH]cn2)n1.O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O
N-[5-(4-[2-(2,2,2-trifluoroethyl)guanidino]pyrimid-2-yl)pentyl]-3-(imidazol-4-yl)propionamide bis maleate hemihydrate

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.STIRRINGstirring
  2. 2
    workup.WAITwas continued at room temperature for 16 hours
  3. 3
    SonstigeThe mixture was evaporated
  4. 4
    Sonstigethe residue partitioned between EtOAc and 2N aqueous HCl
  5. 5
    Extraktionextracted with EtOAc
  6. 6
    Trocknendried (MgSO4)
  7. 7
    Sonstigeevaporated to dryness
  8. 8
    workup.DISSOLUTIONThe residual gum was dissolved in EtOAc
  9. 9
    workup.ADDITIONtreated with excess of a solution of maleic acid in EtOAc
  10. 10
    FiltrationThe resulting solid was filtered
  11. 11
    Sonstigerecrystallised from EtOH/EtOAc

Vorschrift

Ethyl chloroformate (0.14 ml.) was added to a stirred mixture of 3-(imidazol-4-yl)propionic acid (0.3 g.) and triethylamine (2 ml.) in DMF (5 ml.) at 0° and the mixture stirred at 0° for 0.5 hours. 4-[2-(2,2,2-Trifluoroethyl)guanidino]-2-(5-aminopentyl)pyrimidine (0.3 g.) in DMF (2 ml.) was added to the mixture and stirring was continued at room temperature for 16 hours. The mixture was evaporated and the residue partitioned between EtOAc and 2N aqueous HCl. The acid layer was basified with 11N aqueous NaOH, extracted with EtOAc, dried (MgSO4) and evaporated to dryness. The residual gum was dissolved in EtOAc and treated with excess of a solution of maleic acid in EtOAc. The resulting solid was filtered and recrystallised from EtOH/EtOAc to give N-[5-(4-[2-(2,2,2-trifluoroethyl)guanidino]pyrimid-2-yl)pentyl]-3-(imidazol-4-yl)propionamide bis maleate hemihydrate (containing 0.5 EtOH of crystallisation) (0.2 g.), m.p. 136°-141° (decomp.).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US04657908uspto-grants-1987_04